JP2022525779A5 - - Google Patents
Info
- Publication number
- JP2022525779A5 JP2022525779A5 JP2021556419A JP2021556419A JP2022525779A5 JP 2022525779 A5 JP2022525779 A5 JP 2022525779A5 JP 2021556419 A JP2021556419 A JP 2021556419A JP 2021556419 A JP2021556419 A JP 2021556419A JP 2022525779 A5 JP2022525779 A5 JP 2022525779A5
- Authority
- JP
- Japan
- Prior art keywords
- administered
- bis
- pharmaceutically acceptable
- acceptable salt
- lymphoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962820767P | 2019-03-19 | 2019-03-19 | |
| US62/820,767 | 2019-03-19 | ||
| PCT/US2020/023537 WO2020191144A1 (en) | 2019-03-19 | 2020-03-19 | Therapeutic methods and compositions for treating lymphoma using 6,8-bis-benzylthio-octanoic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525779A JP2022525779A (ja) | 2022-05-19 |
| JP2022525779A5 true JP2022525779A5 (https=) | 2023-12-19 |
Family
ID=72519349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556419A Pending JP2022525779A (ja) | 2019-03-19 | 2020-03-19 | ６，８－ビス－ベンジルチオ－オクタン酸を使用してリンパ腫を治療するため治療方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220151994A1 (https=) |
| EP (1) | EP3941453A4 (https=) |
| JP (1) | JP2022525779A (https=) |
| KR (1) | KR20220018959A (https=) |
| CN (1) | CN114040758A (https=) |
| AU (1) | AU2020240091A1 (https=) |
| BR (1) | BR112021018138A2 (https=) |
| CA (1) | CA3133101A1 (https=) |
| MX (1) | MX2021011250A (https=) |
| TW (1) | TW202102211A (https=) |
| WO (1) | WO2020191144A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3121645A1 (en) * | 2018-12-20 | 2020-06-25 | Rafael Pharmaceuticals, Inc. | Oral therapy using 6,8-bis-benzylthio-octanoic acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8263653B2 (en) * | 2007-04-18 | 2012-09-11 | Cornerstone Pharmaceuticals, Inc. | Pharmaceutical formulations containing lipoic acid derivatives |
-
2020
- 2020-03-19 MX MX2021011250A patent/MX2021011250A/es unknown
- 2020-03-19 CN CN202080022886.3A patent/CN114040758A/zh active Pending
- 2020-03-19 CA CA3133101A patent/CA3133101A1/en active Pending
- 2020-03-19 EP EP20774107.5A patent/EP3941453A4/en not_active Withdrawn
- 2020-03-19 KR KR1020217033115A patent/KR20220018959A/ko active Pending
- 2020-03-19 TW TW109109207A patent/TW202102211A/zh unknown
- 2020-03-19 WO PCT/US2020/023537 patent/WO2020191144A1/en not_active Ceased
- 2020-03-19 US US17/440,229 patent/US20220151994A1/en not_active Abandoned
- 2020-03-19 BR BR112021018138A patent/BR112021018138A2/pt unknown
- 2020-03-19 AU AU2020240091A patent/AU2020240091A1/en not_active Abandoned
- 2020-03-19 JP JP2021556419A patent/JP2022525779A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6271254B1 (en) | Pharmaceutical compositions containing R-α-lipoic acid or S-α-lipoic acid as active ingredient | |
| AU2007230716B2 (en) | Formulations of low dose diclofenac and beta-cyclodextrin | |
| JP2022525149A5 (https=) | ||
| JP2023535744A5 (https=) | ||
| IL314873A (en) | Compositions and methods for treating disorders ameliorated by muscarnic receptor activation | |
| RU2010140682A (ru) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство | |
| CN1344159B (zh) | 有关血管生成疾病的治疗组合 | |
| RU2018121615A (ru) | Модуляторы активности комплемента | |
| ES2755303T3 (es) | Composición medicinal para potenciar la síntesis de protoporfirina IX | |
| JP2025148449A5 (https=) | ||
| JP2023517535A5 (https=) | ||
| JP2023500020A5 (https=) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2022525779A5 (https=) | ||
| RU2006124557A (ru) | Композиции и способы введения средств, связывающих тубулин, для лечения глазных заболеваний | |
| JPWO2020250915A5 (https=) | ||
| JP2024517085A5 (https=) | ||
| CN109925316B (zh) | 一种治疗溃疡性结肠炎的药物 | |
| KR20120138229A (ko) | 정맥내 투여용 이부프로펜을 이용한 중증 환자의 치료 | |
| JP2022550828A5 (https=) | ||
| JP2025517509A5 (https=) | ||
| JP2024516003A5 (https=) | ||
| CN116113411A (zh) | 用于治疗软组织肉瘤的联用药物 | |
| IL319025A (en) | Methods for treating or preventing endometriosis | |
| IL319451A (en) | HIV treatment with CABOTEGRAVIR and RILPIVIRINE in pediatric patients |